Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 22 Jan 21 EFFECT Notice of effectiveness
- 20 Jan 21 POS AM Prospectus update (post-effective amendment)
- 13 Oct 20 424B4 Prospectus supplement with pricing info
- 9 Oct 20 EFFECT Notice of effectiveness
- 8 Oct 20 S-1/A IPO registration (amended)
- 7 Oct 20 S-1/A IPO registration (amended)
- 6 Oct 20 FWP Free writing prospectus
-
6 Oct 20 S-1/A IPO registration (amended)
- 28 Sep 20 S-1 IPO registration
ARTL similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in this Registration Statement on Form S-1 of our report dated November 25, 2019 with respect to the audited consolidated financial statements of Artelo Biosciences, Inc. and its subsidiaries for the years ended August 31, 2019 and 2018. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the references to us under the heading “Experts” in such Registration Statement.
/s/ MaloneBailey, LLP
www.malonebailey.com
Houston, Texas
September 28, 2020